Literature DB >> 24648902

Clinicopathological differences of colorectal cancers according to tumor origin: Identification of possibly de novo lesions.

Petros C Papagiorgis1, Adamantia E Zizi2, Sophia Tseleni3, Ioannis N Oikonomakis4, Nikolaos I Nikiteas5.   

Abstract

Colorectal cancer (CRC) is considered to develop through the conventional adenoma-carcinoma sequence. However, the existence of de novo carcinogenesis, without any intervening precursor lesions, has been suggested for certain morphologically different tumors lacking polypoid characteristics. The presence of such tumors, along with their correlation with cardinal clinicopathological parameters, such as stage, grade and site, was retrospectively investigated in a series of 119 surgically treated CRC cases. The absence of particular polypoid characteristics (adenomatous remnants or coexisting polyps in the tumor vicinity) in combination with an infiltrative (or ulceroinfiltrative) growth pattern, were the criteria defining the nonpolypoid origin. The recorded frequencies of remnants, coexisting polyps and infiltrative tumors were 7, 5, 9 and 32%, respectively. The incidence of cases meeting the above-mentioned criteria was 28.5%. These nonpolypoid lesions exhibited a predilection for proximal anatomical site (P=0.04), probably associated with their infiltrative pattern. Most importantly, de novo lesions (unlike polypoid) were rarely found among cases with indolent tumor characteristics (stage I or grade I, P=0.008), showing a considerably different overall pattern of distribution by stage and grade as compared to that of polypoid tumors (P=0.03). The fact that nonpolypoid CRCs appeared to be clinicopathologically different from their polypoid counterparts is supportive of possible de novo origin and suggestive of a likely worse clinical behavior. The impact of these findings should be investigated to determine potential applications in the diagnosis, treatment and surveillance of these lesions.

Entities:  

Keywords:  colorectal cancer; de novo carcinogenesis; nonpolypoid; polypoid

Year:  2012        PMID: 24648902      PMCID: PMC3956619          DOI: 10.3892/br.2012.17

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  32 in total

1.  Site impact on colorectal cancer biological behavior in terms of clinicopathological and molecular features.

Authors:  P C Papagiorgis; A E Zizi; S Tseleni; I N Oikonomakis; L Sofras; I S Elemenoglou; E Patsouris; N I Nikiteas
Journal:  J BUON       Date:  2011 Jan-Mar       Impact factor: 2.533

Review 2.  Prevalence and clinicopathological features of nonpolypoid colorectal neoplasms: should we pay more attention to identifying flat and depressed lesions?

Authors:  Takahisa Matsuda; Yutaka Saito; Kinichi Hotta; Yasushi Sano; Takahiro Fujii
Journal:  Dig Endosc       Date:  2010-07       Impact factor: 7.559

3.  President's address. The polyp-cancer sequence in the large bowel.

Authors:  B Morson
Journal:  Proc R Soc Med       Date:  1974-06

4.  Proportion of de novo cancers among colorectal cancers in Japan.

Authors:  Hideyo Goto; Yasushi Oda; Yoshitaka Murakami; Tomofumi Tanaka; Kiwamu Hasuda; Sayoko Goto; Yutaka Sasaki; Shotaro Sakisaka; Masahiro Hattori
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

5.  Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.

Authors:  Akiko Yasugi; Kazuo Yashima; Akihito Hara; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Hironobu Andachi; Yoshikazu Murawaki
Journal:  Oncol Rep       Date:  2008-01       Impact factor: 3.906

6.  Early colorectal carcinoma with special reference to its development de novo.

Authors:  T Shimoda; M Ikegami; J Fujisaki; T Matsui; S Aizawa; E Ishikawa
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

7.  A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy.

Authors:  C-D Chen; M-F Yen; W-M Wang; J-M Wong; T H-H Chen
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

8.  Colorectal carcinogenesis: Review of human and experimental animal studies.

Authors:  Takuji Tanaka
Journal:  J Carcinog       Date:  2009

9.  Clinical implications and utility of field cancerization.

Authors:  Gabriel D Dakubo; John P Jakupciak; Mark A Birch-Machin; Ryan L Parr
Journal:  Cancer Cell Int       Date:  2007-03-15       Impact factor: 5.722

10.  Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth.

Authors:  K Kaneko; T Kurahashi; R Makino; K Konishi; H Ito; A Katagiri; Y Kumekawa; Y Hirayama; K Yoneyama; M Kushima; M Kusano; H Tajiri; B J Rembacken; K Mitamura; M Imawari
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more
  4 in total

1.  Aberrant expression of MYD88 via RNA-controlling CNOT4 and EXOSC3 in colonic mucosa impacts generation of colonic cancer.

Authors:  Masumi Tsuda; Misa Noguchi; Tsuyoshi Kurai; Yuji Ichihashi; Koki Ise; Lei Wang; Yusuke Ishida; Mishie Tanino; Satoshi Hirano; Masahiro Asaka; Shinya Tanaka
Journal:  Cancer Sci       Date:  2021-10-25       Impact factor: 6.716

2.  Magnifying endoscopic findings of early-stage poorly differentiated colorectal adenocarcinoma: a case report.

Authors:  Haiyan Li; Yao Liu; Jianhong Zhu
Journal:  BMC Gastroenterol       Date:  2022-03-28       Impact factor: 3.067

3.  Pathological Characteristics, Prognostic Determinants and the Outcome of Patients Diagnosed with Colorectal Adenocarcinoma at the University Teaching Hospital of Kigali.

Authors:  Delphine Uwamariya; Déogratias Ruhangaza; Belson Rugwizangoga
Journal:  Can J Gastroenterol Hepatol       Date:  2022-09-20

4.  Single-centre evaluation and staging of rectal carcinoma on a 3-Tesla magnetic resonance imaging and correlation with histological profile.

Authors:  Jandos Amankulov; Galiya Akhmetova; Dias Toleshbaev; Zhamilya Zholdybay; Laura Mangitova; Dilyara Kaidarova
Journal:  Pol J Radiol       Date:  2021-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.